Yahoo MoviesNerlens Noel with a dunk vs the Indiana Pacers
Nerlens Noel (New York Knicks) with a dunk vs the Indiana Pacers, 02/27/2021
Nerlens Noel (New York Knicks) with a dunk vs the Indiana Pacers, 02/27/2021
Move your desk up and down with a simple push of a button.
The Academy Awards goes down on Sunday, April 25, 2021
The "Metal Cutting Machines (MCM) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
A ‘TERRIBLE’ season may have ended in a first-round World Snooker Championship exit for Gary Wilson but he finally believes the green shoots of recovery are starting to show
The CERT-In is India’s nodal agency to deal with cyber security threats like hacking and phishing
The insurance technology company says it is working an a new and secret project. Whatever it is, it should add long-term value.
Global Cold-pressed Juices Market In Europe 2021-2025 The analyst has been monitoring the cold-pressed juices market in Europe and it is poised to grow by $ 54. 70 mn during 2021-2025 progressing at a CAGR of almost 6% during the forecast period.New York, April 20, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cold-pressed Juices Market in Europe 2021-2025" - https://www.reportlinker.com/p05893400/?utm_source=GNW Our report on cold-pressed juices market in Europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.The report offers an up-to-date analysis regarding the current Europe market scenario, latest trends and drivers, and the overall market environment. The market is driven by the high nutritional value and new product launches. In addition, high nutritional value is anticipated to boost the growth of the market as well.The cold-pressed juices market in Europe analysis include product segment and geographical landscapesThe cold-pressed juices market in Europe is segmented as below:By Product• Conventional• OrganicBy Geographical Landscape• UK• Germany• France• Rest of EuropeThis study identifies the growing number of cold-pressed juice bars as one of the prime reasons driving the cold-pressed juices market in Europe growth during the next few years.The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on cold-pressed juices market in Europe covers the following areas:• Cold-pressed juices market in Europe sizing• Cold-pressed juices market in Europe forecast• Cold-pressed juices market in Europe industry analysisThis robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cold-pressed juices market in Europe vendors that include B.fresh Foods LLP, Detox Delight GmbH & Co.KG, Hoogesteger , PepsiCo Inc., Plenish Cleanse Ltd., REJUCE, Robinson Beverages LLC, Starbucks Corp., The Hain Celestial Group Inc., and The Juice Warrior. Also, the cold-pressed juices market in Europe analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.Read the full report: https://www.reportlinker.com/p05893400/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
Dublin, April 20, 2021 (GLOBE NEWSWIRE) -- ResearchAndMarkets.com published a new article on the virus detection industry "GE Working on Sensor to Detect COVID Virus"General Electric announced that it is working on a sensor that could detect COVID-19 virus particles on surfaces."One of the first lines of defence against any virus is avoiding exposure, which is easier said than done when you can't see it," Radislav Potyrailo, a principal scientist at GE Research. "We are developing a sensor small enough to embed in a mobile device that could detect the presence of the COVID-19 virus." The company said the sensors could be "smaller than a fingertip" and be programmed to detect the presence of other diseases as well. The article on ResearchAndMarkets.com contains a selection of reports on virus detection such as: Hot ICs: A Market Analysis of Artificial Intelligence (AI), 5G, CMOS Image Sensors, and Memory ChipsGlobal Telemedicine Services and Equipment Market2020 Clinical Trial Analytics of the Microbiome Landscape To see the full article and a list of related reports on the market, visit "GE Working on Sensor to Detect COVID Virus" About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
New York, New York--(Newsfile Corp. - April 20, 2021) - Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders FibroGen, Inc. (NASDAQ: FGEN).CLICK HERE FOR MORE DETAILS:https://claimyourloss.com/securities/fibrogen-inc-loss-submission-form/?id=14895&from=5Affected shareholders purchased shares of FGEN between November 8, 2019 and April 6, 2021Shareholders interested in representing the class of wronged shareholders have until June 11, 2021 to petition the court. Your ability to share in any recovery doesn't require that ...
Meanwhile, eight in 10 of these jobs were lost by workers under the age of 35.
Parisians yearning for haute cuisine dining since the COVID-19 pandemic closed down restaurants have found an alternative: private chefs who serve up meals in customers' homes. Fatiha El-Kaddaoui is a trained chef who takes bookings from private individuals, brings her ingredients to their home and uses their equipment to prepare and serve restaurant-quality dishes. Last Friday, El-Kaddaoui had been booked by Valerie Lacroix, 35, to prepare a lunch for her and her mother.
ASML Holding NV, one of the biggest suppliers to semiconductor companies, is likely to show its order books are full to bursting because of a global chip shortage when it reports first quarter earnings on Wednesday. ASML will benefit from major investment plans unveiled by key customers TSMC, Samsung and Intel in recent weeks, and the focus will be on how much equipment it can deliver this year, as well as any plans to expand capacity. The chip shortage comes as carmakers, which shut plants during the COVID-19 pandemic last year, ramp up production, and as consumers stock up on laptops, gaming consoles and other electronic products.
A 30-year-old cyclist has been left fighting for life after a collision with a van in east London. Police were called to Bow Roundabout, close to the A12 at 10:25am on Monday. Officers and the London Ambulance Service rushed to the scene and the cyclist was taken to an east London hospital where he remains in critical condition.
A British parliamentary committee will summon finance minister Rishi Sunak and former Prime Minister David Cameron to appear before it to answer questions about the ex-leader's lobbying for the now failed supply-chain finance firm Greensill Capital. Greensill's founder, Lex Greensill, Bank of England Governor Andrew Bailey and the chief executive of the Financial Conduct Authority, Nihkil Rathi, will also face questions about the collapse of the company and Cameron's actions.
Samir Jassal is also a former parliamentary candidate and councillor who has campaigned with Boris Johnson
The average price of a home in the UK is now £327,797 after an increase of 2.1 per cent — or £6,733 — in a month.
BOGOTÁ, Columbia, April 20, 2021 (GLOBE NEWSWIRE) -- A new business intelligence report released by Data Bridge Market Research with title “Global Vaccine Market Size, Share, Growth, Industry Trends Analysis and Forecast 2028 with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery” is designed covering micro level of analysis by manufacturers and key business segments. The Global Vaccines Market survey analysis offers energetic visions to conclude and study market size, trends, growth, demand, revenue, market share by company and competitive surroundings. This report also provides SWOT Analysis with potential market opportunities for evaluating the Overall Market, underlining opportunities, and supporting strategic and tactical decision-making for New Project Investments valuable source of guidance for companies and individuals. Some of the key players profiled in the study are Bharat Biotech, Biological E Limited, Bio Farma, Emergent BioSolutions, etc. DBMR analyses that the Vaccines Market is growing with a CAGR of 6.9% in the forecast period of 2021 to 2028 and is expected to reach USD 61,988.47 million by 2028. Get Download Exclusive PDF Sample Copy of this Report to understand the structure of the complete Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-vaccines-market The Vaccines Industry will relinquish an approximated estimate at a frequency of 6.9% for the projection space of 2021 to 2028 with factor such as the high prevalence of chronic condition such as flu and bacterial infectious diseases. Increase in awareness and campaigns related to vaccination can also drive the market growth of vaccines. Improvement in the treatment and innovation of newer vaccines has accelerated the vaccines market growth. However, high cost and differences in pricing may hamper the vaccines market growth. Some of the Key Players/Manufacturers involved in the Market are – Bharat BiotechBiological E LimitedBio FarmaEmergent BioSolutions Inc.Dynavax TechnologiesValneva SEBavarian NordicAltimmuneMerck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.)Takeda Pharmaceutical Company LimitedSeqirus (a subsidiary of CSL Limited)AbbottAstraZenecaSanofiPfizer Inc.F. Hoffmann-La Roche LtdDAIICHI SANKYO COMPANY, LIMITEDALKPanacea Biotec LtdGlaxoSmithKline plc Access Full Report Directly @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-vaccines-market Vaccine Market Overview:According to Data Bridge Market Research, the market for vaccines in North America region has the highest market share followed by Europe and Asia-Pacific. Market leader is GlaxoSmithKline Plc which accounts an estimated market share of approximately 21.43% in the global market. The company has gained outstanding sale by providing the innovative vaccines to the market. In November 2020, GlaxoSmithKline plc along with Medicines for Malaria Venture presented a positive data (TEACH study) of tafenoquine used for the treatment of Plasmodium vivax malaria in children and adolescents. During the four months of examination, 95% of studied 60 subjects that did not show the signs of Plasmodium vivax malaria. The results were presented through virtual annual meeting of American Society of Tropical Medicine & hygiene 2020. This has helped the company to move forward on the product for the treatment of malaria and to provide the evidence of their product. The Global Vaccine Market 2021 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Vaccine market report is provided for the international markets as well as development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report additionally states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. Know more details about Global Vaccine Market click here @ https://www.databridgemarketresearch.com/reports/global-Vaccines-market COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations travel bans and quarantines restaurants closed all indoor events restricted over forty countries state of emergency declared massive slowing of the Vaccine market volatility falling business confidence, growing panic among the population, and uncertainty about future.The segments and sub-section of Vaccine market are shown below: The Study is segmented by following Product Type: (Subunit, Recombinant, Polysaccharide & Conjugate Vaccines, Live-Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, DNA Vaccines), Kind (Routine Vaccine, Recommended Vaccine, Required Vaccine) By Composition (Combination Vaccines, Monovaccines) By Age of Administration (Pediatric Vaccine, Adult Vaccine) By Diseases (Pneumococcal Disease, Measles, Mumps & Varicella, DPT, Hepatitis, Influenza, Typhoid, Meningococcal, Rabies, Japanese Encephalitis, Yellow Fever, Others) By Route of Administration (Injectable, Oral, Nasal) Major applications/end user’s industries are as follows: End User (Community Hospitals, Hospitals, Specialty Centres, Clinics, Others) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) The report also focuses on global major leading industry players of worldwide Vaccine Market providing information like company profiles, product picture and specification, capacity, production, price, cost, revenue and get in touch with information. Upstream raw materials and equipment and downstream demand analysis is additionally administered. The worldwide Vaccine market development trends and marketing channels are analyzed. Finally, the feasibility of latest investment projects is assessed and overall research conclusions offered. Key Answers Captured in Study are Which geography would have better demand for product/services?What strategies of big players help them acquire share in regional market?Countries that may see the steep rise in CAGR & year-on-year (Y-O-Y) growth?How feasible is market for long term investment?What opportunity the country would offer for existing and new players in the Vaccine market?Risk side analysis involved with suppliers in specific geography?What influencing factors driving the demand of Vaccine near future?What is the impact analysis of various factors in the Global Vaccine market growth?What are the recent trends in the regional market and how successful they are? Complete Report is Available (Including Full TOC, List of Tables & Figures, Graphs and Chart) @ https://www.databridgemarketresearch.com/toc/?dbmr=global-vaccines-market Trends Impacting the Vaccines MarketNow the question is which other regions GlaxoSmithKline plc, Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.) and Sanofi are targeting? Data Bridge Market Research has forecasted a large growth in North America vaccines market and the market leaders targeting the U.S. and Canada to be their next revenue pockets for 2021. The Vaccines Market is becoming more competitive with companies such as GlaxoSmithKline plc, Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.) and Sanofi as they are the top dominating companies in vaccines market and are launching more new therapies in the market. The Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global vaccines market. If opting for the Global version of Vaccine Market analysis is provided for major regions as follows: North America (USA, Canada and Mexico)Europe (Germany, France, the United Kingdom, Netherlands, Russia, Italy and Rest of Europe)Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India and Southeast Asia)South America (Brazil, Argentina, Colombia, rest of countries etc.)Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Nigeria and South Africa) Important years considered in the study are: Historical year – 2010-2020Base year – 2020Forecast period** – 2021 to 2028 [** unless otherwise stated] For More Information or Query or Looking for Customization, Visit @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-vaccines-market Vaccines Market Scope and Market SizeThe vaccines market is segmented on the basis of composition, type, kind, age of administration, diseases, route of administration, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. On the basis of composition, the vaccines market is segmented into combination vaccines, monovaccines. In 2021, combination vaccines segment is dominating the market because combination vaccines are effective against multiple diseases by administration of a single shot.On the basis of type, the vaccines market is segmented into subunit, recombinant, polysaccharide and conjugate vaccines, live-attenuated vaccines, inactivated vaccines, toxoid vaccines and DNA vaccines. In 2021, subunit, recombinant, polysaccharide and conjugate vaccine segment is dominating the market because these vaccines have been reported to induce strong immune response on almost everyone who needs them including people with weakened immune systems and long-term health problems.On the basis of kind, the vaccines market is segmented into routine vaccine, recommended vaccine and required vaccine. In 2021, routine vaccine segment is dominating the market because these are mostly used for childhood vaccination and government is putting major emphasis on childhood vaccination all over the world.On the basis of age of administration, the vaccines market is segmented into pediatric vaccine and adult vaccine. In 2021, pediatric vaccine segment is dominating the market because children are more prone to infectious disease among other due to developing immune system and hence needs proper vaccination.On the basis of diseases, the vaccines market is segmented into pneumococcal disease, measles, mumps & varicella, DPT, hepatitis, influenza, typhoid, meningococcal, rabies, Japanese encephalitis, yellow fever and others. In 2021, pneumococcal disease segment is dominating the market because of rising prevalence on pneumonia infection and increasing immunization campaign launch for the betterment of the population.On the basis of route of administration, the vaccines market is segmented into injectable, oral and nasal. In 2021, injectable segment is dominating the market because most of the vaccines are administered via parenteral route and induces strong systemic response when injected via same route. To Be Continued There are 15 Chapters to display the Global Vaccine market.Chapter 1, About Executive Summary to describe Definition, Specifications and Classification of Global Vaccine market, Applications, Market Segment by Types;Chapter 2, objective of the study.Chapter 3, to display Research methodology and techniques.Chapter 4 and 5, to show the Vaccine Market Analysis, segmentation analysis, characteristics;Chapter 6 and 7, to show Five forces (bargaining Power of buyers/suppliers), Threats to new entrants and market condition;Chapter 8 and 9, to show analysis by regional segmentation[North America (Covered in Chapter 9), United States, Canada, Mexico, Europe (Covered in Chapter 10), Germany, UK, France, Italy, Spain, Russia, Others, Asia-Pacific (Covered in Chapter 11), China, Japan, South Korea, Australia, India, South America (Covered in Chapter 12), Brazil, Argentina, Columbia, Middle East and Africa (Covered in Chapter 13), UAE, Egypt & South Africa ], comparison, leading countries and opportunities; Regional Marketing Type Analysis, Supply Chain AnalysisChapter 10, to identify major decision framework accumulated through Industry experts and strategic decision makers;Chapter 11 and 12, Global Vaccine Market Trend Analysis, Drivers, Challenges by consumer behavior, Marketing ChannelsChapter 13 and 14, about vendor landscape (classification and Market Ranking)Chapter 15, deals with Global Vaccine Market sales channel, distributors, Research Findings and Conclusion, appendix and data source.Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia or Oceania [Australia and New Zealand]. Browse Trending Related Reports: Companion Animal Vaccines Market By Product Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines), Species Type (Canine, Avian, Feline, Equine), Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Retail Pharmacies and Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2026 https://www.databridgemarketresearch.com/reports/global-companion-animal-vaccines-market Veterinary/Animal Vaccines Market By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines, Other Animal Vaccines), Disease (Porcine, Poultry, Livestock, Companion Animals, Aquaculture), Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines), Route of Administration (Oral, Parenteral, Topical), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026 https://www.databridgemarketresearch.com/reports/global-veterinaryanimal-vaccines-market DNA Vaccines Market By Types (Human DNA Vaccines, Animal DNA Vaccines), Technology (pDNA Vaccines Technology, pDNA Delivery Technology), Application (Human Diseases, Veterinary Diseases Allergies, Others), End- User (Human Health, Animal Health, Research Application), Therapeutic Indications (Vector Borne Disease, Cancer), Type of Vaccines (Genetic Vaccines, Recombinant Protein Vaccines), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends & Forecast to 2026 https://www.databridgemarketresearch.com/reports/global-dna-vaccines-market Personalized Cancer Vaccines Market By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma), By Mechanism of action Type (Tumor-associated antigens (TAAs), Tumor-specific antigens (TSAs), Somatic Mutations in Cancer Pharmacogenomics, Pharmacogenomics towards Genomic Polymorphism),By Biomaker Type (Pharmacogenomic, Prognostic and Predictive Biomarkers, Immune Checkpoint Biomarkers and Others), By therapy Type (Immunotherapy), By Route of Administration (Injectabls), By End- users (Hospitals, Homecare, Specialty Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends & Forecast to 2026 https://www.databridgemarketresearch.com/reports/global-personalized-cancer-vaccines-market Conjugate Vaccines Market, By Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccines), Indication (Pneumococcal Disease, Influenza, Meningococcal Disease, Others), End-Users (Hospitals, homecare, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2027 https://www.databridgemarketresearch.com/reports/global-conjugate-vaccines-market About Data Bridge Market Research:An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9% client satisfying rate. Contact:Data Bridge Market ResearchUS: +1 888 387 2818UK: +44 208 089 1725Hong Kong: +852 8192 7475Email - corporatesales@databridgemarketresearch.com
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeBally's Corporation(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure19/04/2021(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”YES / NO / N/AIf YES, specify which: Offeree: Gamesys Group plc 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security:USD 0.01 common InterestsShort positionsNumber%Number%(1) Relevant securities owned and/or controlled: 522,900 1.6395 (2) Cash-settled derivatives: 2,549 0.0080 (3) Stock-settled derivatives (including options) and agreements to purchase/sell: - 0 TOTAL: 525,449 1.6475 All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors’ and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant securityPurchase/saleNumber of securitiesPrice per unitUSD 0.01 commonPurchase7658.19USD 0.01 commonPurchase1,50056.66 (b) Cash-settled derivative transactions Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit (ii) Exercise Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none” (c) Attachments Is a Supplemental Form 8 (Open Positions) attached?YES/NO Date of disclosure:20/04/2021Contact name:Abdi MusseTelephone number:+442071443164 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
After the beauty influencer admitted to messaging two underage boys, YouTube and the beauty world are distancing themselves.
Sir Michael Oswald died after a long illness.